Physicians and researchers have been trying to defeat TB for centuries.
And new research from the Translational Genomics Research Institute, or TGen, suggests there’s promise in preventing patients from developing a resistance to tuberculosis drugs.
With me to explain is Dr. David Engelthaler, co-director of TGen’s Pathogen Genomics Division.
